392 related articles for article (PubMed ID: 26582104)
1. A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs.
Gidwani B; Vyas A
Biomed Res Int; 2015; 2015():198268. PubMed ID: 26582104
[TBL] [Abstract][Full Text] [Related]
2. Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: A review.
Mura P
Int J Pharm; 2020 Apr; 579():119181. PubMed ID: 32112928
[TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs.
Duchene D; Cavalli R; Gref R
Curr Pharm Biotechnol; 2016; 17(3):248-55. PubMed ID: 26517333
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional co-transport carriers based on cyclodextrin assembly for cancer synergistic therapy.
Yi S; Liao R; Zhao W; Huang Y; He Y
Theranostics; 2022; 12(6):2560-2579. PubMed ID: 35401819
[TBL] [Abstract][Full Text] [Related]
5. Amphiphilic cyclodextrin nanoparticles for effective and safe delivery of anticancer drugs.
Bilensoy E
Adv Exp Med Biol; 2015; 822():201. PubMed ID: 25416992
[No Abstract] [Full Text] [Related]
6. Cyclodextrin-Based Arsenal for Anti-Cancer Treatments.
Chopra H; Verma R; Kaushik S; Parashar J; Madan K; Bano A; Bhardwaj R; Pandey P; Kumari B; Purohit D; Kumar M; Bhatia S; Rahman MH; Mittal V; Singh I; Kaushik D
Crit Rev Ther Drug Carrier Syst; 2023; 40(2):1-41. PubMed ID: 36734912
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review.
Tian B; Hua S; Liu J
Carbohydr Polym; 2020 Mar; 232():115805. PubMed ID: 31952603
[TBL] [Abstract][Full Text] [Related]
8. Amphiphilic Cyclodextrin Derivatives for Targeted Drug Delivery to Tumors.
Erdogar N; Varan G; Bilensoy E
Curr Top Med Chem; 2017; 17(13):1521-1528. PubMed ID: 28017158
[TBL] [Abstract][Full Text] [Related]
9. The application of nanosponges to cancer drug delivery.
Trotta F; Dianzani C; Caldera F; Mognetti B; Cavalli R
Expert Opin Drug Deliv; 2014 Jun; 11(6):931-41. PubMed ID: 24811423
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrins as Carriers in Targeted Delivery of Therapeutic Agents: Focused Review on Traditional and Inimitable Applications.
Raut SY; Manne ASN; Kalthur G; Jain S; Mutalik S
Curr Pharm Des; 2019; 25(4):444-454. PubMed ID: 30848189
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
[TBL] [Abstract][Full Text] [Related]
12. Nanosponge Carriers- An Archetype Swing in Cancer Therapy: A Comprehensive Review.
Osmani RA; Hani U; Bhosale RR; Kulkarni PK; Shanmuganathan S
Curr Drug Targets; 2017; 18(1):108-118. PubMed ID: 26424399
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems.
Tian B; Liu Y; Liu J
Carbohydr Polym; 2020 Aug; 242():116401. PubMed ID: 32564836
[TBL] [Abstract][Full Text] [Related]
14. Recent Development of Copolymeric Delivery System for Anticancer Agents Based on Cyclodextrin Derivatives.
Feng R; Deng P; Teng F; Song Z
Anticancer Agents Med Chem; 2016; 16(3):299-308. PubMed ID: 26349814
[TBL] [Abstract][Full Text] [Related]
15. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
16. A Mini-Review on Nano Technology in the Tumour Targeting Strategies: Drug Delivery to Cancer Cells.
Kaur L; Sohal HS; Kaur M; Malhi DS; Garg S
Anticancer Agents Med Chem; 2020; 20(17):2012-2024. PubMed ID: 32753024
[TBL] [Abstract][Full Text] [Related]
17. The use of cyclodextrin inclusion complexes to improve anticancer drug profiles: a systematic review.
Gandhi SR; Quintans JSS; Gandhi GR; Araújo AAS; Quintans Júnior LJ
Expert Opin Drug Deliv; 2020 Aug; 17(8):1069-1080. PubMed ID: 32515613
[TBL] [Abstract][Full Text] [Related]
18. Modulating beta-lapachone release from polymer millirods through cyclodextrin complexation.
Wang F; Blanco E; Ai H; Boothman DA; Gao J
J Pharm Sci; 2006 Oct; 95(10):2309-19. PubMed ID: 16883563
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin-Based Nanosystems as Drug Carriers for Cancer Therapy.
Sivakumar PM; Peimanfard S; Zarrabi A; Khosravi A; Islami M
Anticancer Agents Med Chem; 2020; 20(11):1327-1339. PubMed ID: 31490765
[TBL] [Abstract][Full Text] [Related]
20. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
